Summary
MetLife, Inc. filed a Form 8-K on March 31, 2014, to correct previously reported compensation figures in its March 25, 2014, Proxy Statement. Specifically, the company corrected the grant date fair value of equity incentive plan awards for five Named Executive Officers. The original reported values were higher than the actual grant date fair value, which has now been adjusted to be consistent with other compensation disclosures. The correction primarily impacts the estimated future payouts under equity incentive plans, including performance shares and performance units. The adjusted grant date fair value per share used for these corrections was $32.20. Investors should note that this filing is a procedural correction and does not indicate any fundamental change in MetLife's financial performance or strategic direction. It is important for investors to refer to the updated information to ensure accurate understanding of executive compensation.
Key Highlights
- 1MetLife Inc. filed an 8-K to correct executive compensation data in its 2014 Proxy Statement.
- 2The correction pertains to the 'Grants of Plan-Based Awards in 2013' table.
- 3Specifically, the grant date fair value of equity incentive plan awards for Named Executive Officers was overstated in the original filing.
- 4The actual grant date fair value per share used for correction is $32.20.
- 5The corrected values ensure consistency with other compensation tables, such as the Summary Compensation Table.
- 6The filing provides revised figures for top executives including Steven A. Kandarian, John C. R. Hele, William J. Wheeler, Martin J. Lippert, and Christopher G. Townsend.